首次系统检测开放科研平台中的生物安全风险内容

AI is transforming life sciences research at unprecedented speed, accelerating discovery across protein structure prediction, genome modeling, and drug development (Jumper et al., 2021; Mak et al., 2024). Yet this rapid advancement, coupled with the open science movement, introduces significant dual-use research concerns that have received limited empirical scrutiny. Here we present the first systematic analysis of dual-use research of concern (DURC) content on open preprint servers. We screened ~52,000 bioRxiv preprints (2024-2025) using a hybrid pipeline of lexical filtering and large language model (LLM) evaluation, scoring metadata across nine DURC, three PEPP, and five governance categories aligned with U.S. and Australia Group oversight frameworks. Our analysis reveals that dual-use-adjacent knowledge is routinely present in openly accessible titles and abstracts, often exceeding established risk thresholds even in studies with legitimate public health objectives. While this mapping captures surface-level information diffusion, it does not measure operational capability, downstream misuse potential, or the substantial technical and biosafety barriers that constrain harmful application. We argue that institutional review processes, funding requirements, and preprint platform policies must evolve to incorporate proactive, metadata-level monitoring without compromising scientific transparency. Ultimately, harmonizing controlled-access mechanisms for high-risk methodologies with open summaries of scientific contributions offers a pragmatic framework for governing AI-accelerated biology at scale.